Abiomed Incorporated

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES. The Company's portfolio of heart support and recovery products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the catheterization lab to the surgical suite, together with interventional cardiologists and surgeons, Abiomed is dedicated to providing the most advanced medical technologies to heart patients, with the ultimate goal of heart recovery and improved quality of life. Abiomed was founded more than two decades ago and is the only company in the world with exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The Company develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. Abiomed is the global leader for products in the acute heart failure market and ships more ventricle assist devices (VADs) than any other company in the world. The Company is focused on expanding its global distribution, fueling innovation and new products to broaden the Company's product portfolio to become the world's circulatory care leader. Key Facts: Year Founded: 1981 Corporate Headquarters: Danvers, Massachusetts European Division: Aachen, Germany Number of Employees: 300+ Product and Service Offerings: Heart Recovery and Assist: BVS 5000 Bi-ventricular Support System and AB5000 Circulatory Support System In Europe, Abiomed offers the IMPELLA® RECOVER® minimally invasive Cardiovascular Support Systems under CE mark approval Heart Replacement: the AbioCor Implantable Replacement Heart, and Under Development the AbioCor II

Contact Details: 33 Cherry Hill Drive Danvers 01923 United States of America Tel: 978 777 5410 Fax: 978 777 8411 Email: abmd@abiomed.com WWW: www.abiomed.com/

Recent Publications by Abiomed Incorporated:
Investigation of the influence of blood flow rate on large vessel cooling in hepatic radiofrequency ablation. Radiofrequency (RF) ablation using high-frequency current has become an...	8th February, 2007	Department of Biomedical Engineering, Ruhr University, Bochum, Germany.	Biomed Tech (Berl). 2006;51(5-6):337-46. DOI Direct Link
Indirect bronchial shunt flow measurements in AbioCor implantable replacement heart recipients. Bronchial shunt flows in the recipients of the electrohydraulic AbioCor...	16th December, 2004	ABIOMED, Inc., Danvers, MA 01923, USA.	ASAIO J. 2004 May-Jun;50(3):211-4.
Vascular tone estimation in patients implanted with the AbioCor implantable replacement heart. The AbioCor implantable replacement heart provides continuous hydraulic...	27th August, 2004	ABIOMED Inc., 22 Cherry Hill Drive, Danvers, MA 01923, U.S.A.	Artif Organs. 2004 Jun;28(6):543-8. DOI Direct Link
Therapeutic potential of implantable replacement hearts. In patients hospitalized with decompensated life-threatening heart...	15th April, 2004	ABIOMED Inc., Danvers, Massachusetts 01923, USA.	Am J Cardiovasc Drugs. 2002;2(5):297-301.
Improved microvessel repair: laser welding with an anti-thrombotic solder. BACKGROUND AND OBJECTIVES: Concentrated protein solutions can be used as...	22nd January, 2003	ABIOMED, Inc., Cherry Hill Drive, Danvers, MA 01923, USA.	Lasers Surg Med. 2002;31(1):36-40. DOI Direct Link
→View more Abiomed Incorporated research publications.

BioNews Results for Abiomed Incorporated:
Abiomed Second Fiscal Quarter 2010 Earnings and Conference Call Notification	Freshnews.com:  Oct 28 2009 2:34PM Matching: abiomed
Abiomed Second Fiscal Quarter 2010 Earnings and Conference Call Notification	SmartBrief:  Oct 28 2009 9:58PM Matching: abiomed
Abiomed Second Fiscal Quarter 2010 Earnings and Conference Call Notification	Genetic Engineering News:  Oct 28 2009 2:19PM Matching: abiomed
Abiomed Presents Results From Two Studies: USpella and MACH II	Cath Lab Digest:  Oct 14 2009 12:09PM Matching: abiomed
Abiomed Presents Results From USpella, First U.S. Registery Evaluation Impella 2.5 VAD	Diagnostic & Invasive Cardiology:  Oct 1 2009 3:43AM Matching: abiomed
Promote your company here: BioNewsCast - Press Release Distribution	→View more Abiomed Incorporated news.

Abiomed Incorporated Clinical Trials:
Protect II, A Prospective, Multicenter Randomized Controlled Trial

Abiomed Incorporated Patents:
US Patent No.	Title
4826477	Connector for blood handling systems
5116305	Curved intra aortic balloon with non-folding inflated balloon membrane
5180378	Laser surgery system
5643172	Tubular circulatory assist device
5662643	Laser welding system
→View more Abiomed Incorporated patents.

Abiomed Incorporated (IOX) Financial information Links from Barchart
IOX Quote from from Barchart.com
IOX Chart from from Barchart.com
IOX Profile from from Barchart.com
IOX Opinion from from Barchart.com
→View more Abiomed Incorporated finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1828 times since April 2007, the link to the organisation's website has been followed 264 times

Recent Search Terms used to find this page: Vascular tone estimation in patients implanted with the AbioCor implantable replacement heart | Abiomed Ltd medical rental | abiomed | bronchial shunt | AbioCor System | abiomed | .

Search for more companies in Danvers

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Abiomed Incorporated